Shalby Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹235
- Today's High:
- ₹258.65
- Open Price:
- ₹258
- 52W Low:
- ₹113.6592
- 52W High:
- ₹235
- Prev. Close:
- ₹257.5
- Volume:
- 121436
Company Statistics
- Market Cap.:
- ₹24.65 billion
- Book Value:
- 86.101
- Revenue TTM:
- ₹8.39 billion
- Operating Margin TTM:
- 10.89%
- Gross Profit TTM:
- ₹2.26 billion
- Profit Margin:
- 8.16%
- Return on Assets TTM:
- 4.48%
- Return on Equity TTM:
- 7.5%
Company Profile
Shalby Limited had its IPO on under the ticker symbol SHALBY.
The company operates in the Healthcare sector and Medical Care Facilities industry. Shalby Limited has a staff strength of 2,678 employees.
Stock update
Shares of Shalby Limited opened at ₹258 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹235 - ₹258.65, and closed at ₹236.9.
This is a -8% slip from the previous day's closing price.
A total volume of 121,436 shares were traded at the close of the day’s session.
In the last one week, shares of Shalby Limited have slipped by -0.34%.
Shalby Limited's Key Ratios
Shalby Limited has a market cap of ₹24.65 billion, indicating a price to book ratio of 1.8352 and a price to sales ratio of 2.2504.
In the last 12-months Shalby Limited’s revenue was ₹8.39 billion with a gross profit of ₹2.26 billion and an EBITDA of ₹1.31 billion. The EBITDA ratio measures Shalby Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Shalby Limited’s operating margin was 10.89% while its return on assets stood at 4.48% with a return of equity of 7.5%.
In Q2, Shalby Limited’s quarterly earnings growth was a positive 4.3% while revenue growth was a positive 16.8%.
Shalby Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 35.8805
- PEG
Its diluted EPS in the last 12-months stands at ₹6.36 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Shalby Limited’s profitability.
Shalby Limited stock is trading at a EV to sales ratio of 2.2149 and a EV to EBITDA ratio of 11.5008. Its price to sales ratio in the trailing 12-months stood at 2.2504.
Shalby Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0.54% and a payout ratio of 49.89%.
Balance sheet and cash flow metrics
- Total Assets
- ₹12.81 billion
- Total Liabilities
- ₹1.94 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 49.89%
Shalby Limited ended 2024 with ₹12.81 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹12.81 billion while shareholder equity stood at ₹9.28 billion.
Shalby Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹1.94 billion in other current liabilities, in common stock, ₹3.80 billion in retained earnings and ₹101.53 million in goodwill. Its cash balance stood at ₹122.44 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹674.22 million.
Shalby Limited’s total current assets stands at ₹5.17 billion while long-term investments were ₹0 and short-term investments were ₹2.03 billion. Its net receivables were ₹1.06 billion compared to accounts payable of ₹879.19 million and inventory worth ₹1.85 billion.
In 2024, Shalby Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Shalby Limited paid ₹0.50 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹236.9
- 52-Week High
- ₹235
- 52-Week Low
- ₹113.6592
- Analyst Target Price
- ₹
Shalby Limited stock is currently trading at ₹236.9 per share. It touched a 52-week high of ₹235 and a 52-week low of ₹235. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹203.94 and 200-day moving average was ₹157.89 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 7688.3% of the company’s stock are held by insiders while 7.4% are held by institutions.
Frequently Asked Questions About Shalby Limited
Similar Industry Stocks (Medical Care Facilities)
Most Active
Top Gainers
Top Losers
About
Shalby Limited operates multi-specialty hospitals primarily in India, North America, Japan, and Indonesia. The company offers arthroscopy, arthroplasty, cardiology, cardiothoracic and vascular surgery, cosmetic and aesthetic, dental cosmetic and implantology, emergency medicine, endocrinology, endoscopy and laparoscopy, ENT surgery, gastroentero surgery, gastroenterology, general medicine and surgery, hair transplant, liver transplant, dermatology, psychiatry, urology, anesthesia, and hip and knee joint replacement services. It also provides infectious disease, infertility and IVF, intensive and critical care, maxillofacial surgery, nephrology, neurosurgery, neurology, obesity surgery, obstetrics and gynecology, oncology, oncosurgery, ophthalmology and glaucoma, orthopedic and trauma, pediatric orthopedic, pathology and microbiology, pediatrics and neonatology, plastic surgery, pulmonology and chest, radiology and imaging, rheumatology, trauma, spine surgery, and urosurgery services, as well as organ donation. In addition, it offers outpatient services, as well as provides educational programs for paramedical students and other healthcare professionals; and homecare services, such as ICU at home, diagnostics, attendants, doctor visit, nursing care, physiotherapy, pharmacy, and medical equipment. The company was formerly known as Shalby Hospitals Limited and changed its name to Shalby Limited in February 2008. Shalby Limited was founded in 1994 and is headquartered in Ahmedabad, India.